These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 32620999)

  • 1. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
    Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
    J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Precision Medicine Is Changing Acute Myeloid Leukemia Therapy.
    Heuser M; Mina A; Stein EM; Altman JK
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():411-420. PubMed ID: 31099617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia.
    Ribeiro S; Eiring AM; Khorashad JS
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic targeting and personalized approaches for AML.
    Roboz GJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.
    DiNardo C; Lachowiez C
    Curr Hematol Malig Rep; 2019 Oct; 14(5):386-394. PubMed ID: 31350639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene mutations in acute myeloid leukemia].
    Yamaguchi H
    Rinsho Ketsueki; 2016; 57(12):2535-2542. PubMed ID: 28090023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.
    Miyamoto K; Minami Y
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Personalized Molecular Therapy for Acute Myeloid Leukemia.
    Engen CB; Hajjar E; Gjertsen BT
    Curr Pharm Biotechnol; 2016; 17(1):20-9. PubMed ID: 26420051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision therapy for acute myeloid leukemia.
    Yang X; Wang J
    J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
    Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Montesinos P
    Expert Rev Hematol; 2020 Oct; 13(10):1057-1065. PubMed ID: 32869672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
    Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
    Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPM1-mutated acute myeloid leukemia: from bench to bedside.
    Falini B; Brunetti L; Sportoletti P; Martelli MP
    Blood; 2020 Oct; 136(15):1707-1721. PubMed ID: 32609823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
    Chung C; Ma H
    Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Relapsed Acute Myeloid Leukemia.
    Thol F; Ganser A
    Curr Treat Options Oncol; 2020 Jun; 21(8):66. PubMed ID: 32601974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How I diagnose and treat NPM1-mutated AML.
    Falini B; Brunetti L; Martelli MP
    Blood; 2021 Feb; 137(5):589-599. PubMed ID: 33171486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.
    Wertheim GB; Hexner E; Bagg A
    Mol Diagn Ther; 2012 Dec; 16(6):357-69. PubMed ID: 23184342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Acute myeloid leukemia: a comprehensive review and 2016 update'.
    De Kouchkovsky I; Abdul-Hay M
    Blood Cancer J; 2016 Jul; 6(7):e441. PubMed ID: 27367478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
    Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
    Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute myeloid leukemia: molecular pathogenesis and new therapeutic strategies].
    Goyama S
    Rinsho Ketsueki; 2016 Feb; 57(2):118-28. PubMed ID: 26935629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children.
    Masetti R; Bertuccio SN; Guidi V; Cerasi S; Lonetti A; Pession A
    Future Oncol; 2020 Nov; 16(33):2747-2762. PubMed ID: 32813587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.